Federated Hermes’s Concert Pharmaceuticals, Inc. CNCE Stock Holding History

Federated Hermes’s Portfolio CNCE Stock Details CNCE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q2	–	Sell	-239	Closed	-$1K	–	2335
2022 Q1	$1K	Sell	239 -2,025	-89%	-$6.42K	﹤0.01%	2152
2021 Q4	$7K	Sell	2,264 -389	-15%	-$1.29K	﹤0.01%	1973
2021 Q3	$9K	Sell	2,653 -3	-0.1%	-$11	﹤0.01%	1998
2021 Q2	$11K	Buy	+2,656	New	+$11.2K	﹤0.01%	1984
2021 Q1	–	Sell	-119	Closed	-$2K	–	2394
2020 Q4	$2K	Buy	119 +27	+29%	+$308	﹤0.01%	2143
2020 Q3	$1K	Sell	92 -2,809	-97%	-$27.7K	﹤0.01%	2222
2020 Q2	$29K	Buy	+2,901	New	+$27.8K	﹤0.01%	1830
2018 Q4	–	Sell	-1,030	Closed	-$15K	–	2350
2018 Q3	$15K	Sell	1,030 -32,231	-97%	-$507K	﹤0.01%	1886
2018 Q2	$560K	Buy	33,261 +440	+1%	+$8.55K	﹤0.01%	1398
2018 Q1	$752K	Buy	32,821 +10,898	+50%	+$242K	﹤0.01%	1298
2017 Q4	$567K	Buy	+21,923	New	+$441K	﹤0.01%	1356
2017 Q2	–	Sell	-200	Closed	-$3K	–	2205
2017 Q1	$3K	Buy	+200	New	+$2.4K	﹤0.01%	2006
2016 Q1	–	Sell	-112	Closed	-$2K	–	2193
2015 Q4	$2K	Buy	+112	New	+$2.43K	﹤0.01%	1977
2015 Q3	–	Sell	-709	Closed	-$11K	–	2075
2015 Q2	$11K	Hold	709	–	–	﹤0.01%	1718
2015 Q1	$11K	Sell	709 -116	-14%	-$1.62K	﹤0.01%	1776
2014 Q4	$11K	Buy	+825	New	+$10.7K	﹤0.01%	1738

Other funds holding CNCE

BVF Inc San Francisco, California $3.14B AUM 249.53% 1-Year Est. Return

RCM

RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return

Perceptive Advisors New York $5.12B AUM 314.02% 1-Year Est. Return

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

ISL

Ingalls & Snyder LLC New York $2.83B AUM 21.61% 1-Year Est. Return

Millennium Management New York $240B AUM 35.51% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

PHP

Parkman Healthcare Partners Stamford, Connecticut $970M AUM 79.46% 1-Year Est. Return

KCM

Kynam Capital Management Princeton, New Jersey $1.62B AUM 138.67% 1-Year Est. Return

Federated Hermes's CNCE Position: Q2 2022 in Review

Federated Hermes sold out of Concert Pharmaceuticals, Inc. (CNCE) in Q2 2022, closing a stake of 239 shares — an estimated $1K sold.

Federated Hermes first reported a position in CNCE in Q4 2014 and held it in 16 quarters. The position peaked at $752K in Q1 2018. 70 funds tracked by Wall St. Rank hold CNCE as of Q2 2022.

Federated Hermes reported no remaining Concert Pharmaceuticals, Inc. position as of Q2 2022 after selling out during the quarter.
Federated Hermes sold 239 Concert Pharmaceuticals, Inc. shares in Q2 2022, an estimated $1K.
Federated Hermes first reported a position in Concert Pharmaceuticals, Inc. in Q4 2014 and held it in 16 quarters.
Federated Hermes's Concert Pharmaceuticals, Inc. position peaked at $752K in Q1 2018.
70 funds tracked by Wall St. Rank held Concert Pharmaceuticals, Inc. as of Q2 2022.

Based on Federated Hermes's 13F filing for Q2 2022, filed 15 Aug 2022.